Industry
EUROS
Total Trials
5
Recruiting
1
Active
4
Completed
1
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
Failure Rate
0.0%
0 terminated/withdrawn out of 5 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed trials have results
Key Signals
1 recruiting
Enrollment Performance
Analytics
N/A
2(100.0%)
2Total
N/A(2)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (5)
Showing 5 of 5 trials
NCT07403084Not ApplicableRecruiting
Post-market Clinical Follow-up Study of NEMOST V2
Role: lead
NCT04993638Active Not Recruiting
Post Market Clinical Follow-up of Dual-mobility Acetabular Cup EUROSCUP MOBILE
Role: lead
NCT05142462Active Not Recruiting
Post Market Clinical Follow-up of EUROSCUP Fixe Acetabular Cup
Role: lead
NCT04995822Active Not Recruiting
Post Market Clinical Follow-up of EUROSTEM Femoral Stem
Role: lead
NCT04021784Not ApplicableCompleted
Limited-efficacy Testing of SDS and NEMOST for Early Onset Neuromuscular Scoliosis
Role: collaborator
All 5 trials loaded